Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Feinberg

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
Plos One|July 15, 2022
Steep rise in drug use-associated infective endocarditis in West Virginia: Characteristics and healthcare utilizationRuchi Bhandari, Talia Alexander, Frank H Annie, et al.
The Journal of Infectious Diseases|June 27, 2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Adriana Andrade, Susan L Rosenkranz, Anthony R Cillo, et al.
Addiction (Abingdon, England)|March 15, 2026
The association between sleep disturbance and stimulant use: A cross-lagged examinationViviana E Horigian, Renae D Schmidt, Daniel J Feaster, et al.
Contemporary Clinical Trials|November 1, 2019
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO studyAlain H Litwin, John Jost, Katherine Wagner, et al.
Journal of Clinical Medicine|June 24, 2022
Sex Differences in Characteristics of Patients with Infective Endocarditis: A Multicenter StudyRuchi Bhandari, Shabnam Tiwari, Talia Alexander, et al.
Circulation|June 21, 2008
Prevention strategies for cardiovascular disease in HIV-infected patientsJames H Stein, Colleen M Hadigan, Todd T Brown, et al.
Journal of Substance Use and Addiction Treatment|April 26, 2026
Data harmonization within the clinical trials network: Strengths, challenges, and opportunities in the era of generative AIRenae D Schmidt, Raymond R Balise, Sophia T Gonzalez, et al.
Plos One|December 25, 2013
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabineNicholas T Funderburg, Adriana Andrade, Ellen S Chan, et al.
The Journal of Infectious Diseases|January 15, 2004
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trialJoseph J Eron, Judith Feinberg, Harold A Kessler, et al.
Journal of Addiction Medicine|January 23, 2025
Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject DrugsElenore P Bhatraju, Judith I Tsui, Moonseong Heo, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Plos One|July 15, 2022
Steep rise in drug use-associated infective endocarditis in West Virginia: Characteristics and healthcare utilizationRuchi Bhandari, Talia Alexander, Frank H Annie, et al.
The Journal of Infectious Diseases|June 27, 2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Adriana Andrade, Susan L Rosenkranz, Anthony R Cillo, et al.
Addiction (Abingdon, England)|March 15, 2026
The association between sleep disturbance and stimulant use: A cross-lagged examinationViviana E Horigian, Renae D Schmidt, Daniel J Feaster, et al.
Contemporary Clinical Trials|November 1, 2019
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO studyAlain H Litwin, John Jost, Katherine Wagner, et al.
Journal of Clinical Medicine|June 24, 2022
Sex Differences in Characteristics of Patients with Infective Endocarditis: A Multicenter StudyRuchi Bhandari, Shabnam Tiwari, Talia Alexander, et al.
Circulation|June 21, 2008
Prevention strategies for cardiovascular disease in HIV-infected patientsJames H Stein, Colleen M Hadigan, Todd T Brown, et al.
Journal of Substance Use and Addiction Treatment|April 26, 2026
Data harmonization within the clinical trials network: Strengths, challenges, and opportunities in the era of generative AIRenae D Schmidt, Raymond R Balise, Sophia T Gonzalez, et al.
Plos One|December 25, 2013
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabineNicholas T Funderburg, Adriana Andrade, Ellen S Chan, et al.
The Journal of Infectious Diseases|January 15, 2004
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trialJoseph J Eron, Judith Feinberg, Harold A Kessler, et al.
Journal of Addiction Medicine|January 23, 2025
Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject DrugsElenore P Bhatraju, Judith I Tsui, Moonseong Heo, et al.
Pageof 17